1. BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN A REAL WORLD SETTING: CLINICAL OUTCOMES AND IMPACT ON QUALITY OF LIFE. (17th June 2021) Authors: Ionova, T.; Andrievskikh, M.; Amdiev, A.; Baryakh, E.; Chang, V.; Endakova, A.; Fadeeva, N.; Husainova, G.; Ivanov, V.; Kaplanov, K.; Kaverina, O.; Kiseleva, M.; Klitochenko, T.; Kurakin, V.; Larionova, O.; Lazareva, D.; Lepik, K.; Lysenko, I.; Melnichenko, V.; Mikhailova, N. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1724: QUALITY OF LIFE AND UNMET NEEDS AMONG PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM PATIENTS: RESULTS OF THE NATIONWIDE SURVEY. (23rd June 2022) Authors: Ionova, T.; Andreevskaya, E.; Babich, E.; Bulieva, N.; Vinogradova, O.; Volodicheva, E.; Voloshin, S.; Glonina, N.; Dubov, S.; Esefieva, N.; Zinina, E.; Ivanova, M.; Klitochenko, T.; Kopylova, A.; Kulagin, A.; Kuchma, G.; Li, O.; Lomaia, E.; Melikyan, A.; Melnichenko, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB2021: QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD): RESULTS OF A REAL-WORLD EVIDENCE STUDY. (23rd June 2022) Authors: Ionova, T.; Vinogradova, O.; Kochkareva, Y.; Ado, E.; Kaplanov, K.; Shirokova, M.; Shelekhova, T.; Levanov, A.; Kopylova, A.; Li, O.; Mitina, T.; Rukavitsyn, O.; Simashova, P.; Anchukova, L.; Babich, E.; Dasheeva, D.; Demchenkova, M.; Dubov, S.; Esenina, T.; Ivanova, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1892 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PB2246: FEATURES OF THE SECRETION OF HEPCIDIN, A SOLUBLE TRANSFERRIN RECEPTOR DEPENDING ON THE TYPE OF ANEMIA IN PATIENTS WITH MALIGNANT NEOPLASMS. (23rd June 2022) Authors: Sakhin, V.; Kryukov, E.; Kazakov, S.; Sotnikov, A.; Gordienko, A.; Gulyaev, N.; Rukavitsyn, O. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PB2252: TREATMENT OF ANEMIA IN PATIENTS WITH GASTROINTESTINAL AND CHRONIC LIVER DISORDERS BASED ON PREDOMINANT PATHOGENETIC FACTOR. (23rd June 2022) Authors: Rybina, O.; Sakhin, V.; Gubkin, A.; Kryukov, E.; Rukavitsyn, O. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0089 FEATURES OF THE SECRETION OF INTERLEUKIN-6, INTERLEUKIN-10, TUMOR NECROSIS FACTOR ALPHA IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH ANEMIA. (2nd June 2020) Authors: Sakhin, V.; Grigoriev, M.; Rukavitsyn, O.; Kryukov, E.; Kazakov, S. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗